AustralieFrV1, Main, Exploration, bibRecordById, pubmed:28736942

Glycaemic control and hypoglycaemia in people with type 2 diabetes switching from twice-daily basal insulin to once-daily insulin glargine 300 U/mL or insulin glargine 100 U/mL (EDITION 1 and EDITION 2 subgroup analysis).

Identifieur interne : 000B33 ( Main/Exploration ); précédent : 000B32; suivant : 000B34

Glycaemic control and hypoglycaemia in people with type 2 diabetes switching from twice-daily basal insulin to once-daily insulin glargine 300 U/mL or insulin glargine 100 U/mL (EDITION 1 and EDITION 2 subgroup analysis).

Auteurs : Ronan Roussel [France] ; Michael C. D'Emden [Australie] ; Miles Fisher [Royaume-Uni] ; F Javier Ampudia-Blasco [Espagne] ; Peter Stella [France] ; Florence Bizet [France] ; Anna M G. Cali [France] ; Carol H. Wysham [États-Unis]

Source :

Diabetes, obesity & metabolism [ 1463-1326 ] ; 2017.

RBID : pubmed:28736942

Abstract

In this post hoc analysis we compared glycaemic control and hypoglycaemia between insulin glargine 300 U/mL (Gla-300) and glargine 100 U/mL (Gla-100) administered once daily in people with type 2 diabetes (T2DM) from the EDITION 1 (basal plus mealtime insulin) and EDITION 2 (basal insulin plus oral antihyperglycaemic drugs) trials who were previously receiving twice-daily insulin. At randomization, 16.9% and 20.0% of people in EDITION 1 and 2, respectively, were receiving twice-daily basal insulin. Glycated haemoglobin change from baseline to Month 6 was similar over 6 months with Gla-300 or Gla-100 (least squares mean difference -0.01%; 95% confidence interval [CI] -0.27 to 0.24] in EDITION 1 and 0.16%; 95% CI -0.25 to 0.57, in EDITION 2). Participants previously receiving twice-daily insulin in EDITION 1 had a lower risk of confirmed (≤3.9 mmol/L [≤70 mg/dL]) or severe hypoglycaemia with Gla-300 vs Gla-100 at night (00:00-05:59 hours), but not at any time (24 hours); in EDITION 2 the risk was reduced at night and any time (24 hours). In conclusion, Gla-300 provided similar glycaemic control with less hypoglycaemia compared with Gla-100 in people with T2DM switching from twice-daily to once-daily basal insulin.

DOI: 10.1111/dom.13071
PubMed: 28736942

Affiliations:

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Glycaemic control and hypoglycaemia in people with type 2 diabetes switching from twice-daily basal insulin to once-daily insulin glargine 300 U/mL or insulin glargine 100 U/mL (EDITION 1 and EDITION 2 subgroup analysis).</title>
<author><name sortKey="Roussel, Ronan" sort="Roussel, Ronan" uniqKey="Roussel R" first="Ronan" last="Roussel">Ronan Roussel</name>
<affiliation wicri:level="3"><nlm:affiliation>INSERM, UMRS 1138, Centre de Recherche des Cordeliers, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>INSERM, UMRS 1138, Centre de Recherche des Cordeliers, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="D Emden, Michael C" sort="D Emden, Michael C" uniqKey="D Emden M" first="Michael C" last="D'Emden">Michael C. D'Emden</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Endocrinology and Diabetes, Royal Brisbane and Women's Hospital, Brisbane, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Endocrinology and Diabetes, Royal Brisbane and Women's Hospital, Brisbane</wicri:regionArea>
<wicri:noRegion>Brisbane</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Fisher, Miles" sort="Fisher, Miles" uniqKey="Fisher M" first="Miles" last="Fisher">Miles Fisher</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Diabetes, Endocrinology and Clinical Pharmacology, Glasgow Royal Infirmary, Glasgow, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Diabetes, Endocrinology and Clinical Pharmacology, Glasgow Royal Infirmary, Glasgow</wicri:regionArea>
<wicri:noRegion>Glasgow</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ampudia Blasco, F Javier" sort="Ampudia Blasco, F Javier" uniqKey="Ampudia Blasco F" first="F Javier" last="Ampudia-Blasco">F Javier Ampudia-Blasco</name>
<affiliation wicri:level="1"><nlm:affiliation>Diabetes Reference Unit, Clinic University Hospital, Valencia, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Diabetes Reference Unit, Clinic University Hospital, Valencia</wicri:regionArea>
<wicri:noRegion>Valencia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Stella, Peter" sort="Stella, Peter" uniqKey="Stella P" first="Peter" last="Stella">Peter Stella</name>
<affiliation wicri:level="3"><nlm:affiliation>Sanofi, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Sanofi, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Bizet, Florence" sort="Bizet, Florence" uniqKey="Bizet F" first="Florence" last="Bizet">Florence Bizet</name>
<affiliation wicri:level="3"><nlm:affiliation>Sanofi, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Sanofi, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Cali, Anna M G" sort="Cali, Anna M G" uniqKey="Cali A" first="Anna M G" last="Cali">Anna M G. Cali</name>
<affiliation wicri:level="3"><nlm:affiliation>Sanofi, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Sanofi, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Wysham, Carol H" sort="Wysham, Carol H" uniqKey="Wysham C" first="Carol H" last="Wysham">Carol H. Wysham</name>
<affiliation wicri:level="2"><nlm:affiliation>Diabetes and Endocrinology Center, Rockwood Clinic, Spokane, Washington.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Washington (État)</region>
</placeName>
<wicri:cityArea>Diabetes and Endocrinology Center, Rockwood Clinic, Spokane</wicri:cityArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:28736942</idno>
<idno type="pmid">28736942</idno>
<idno type="doi">10.1111/dom.13071</idno>
<idno type="wicri:Area/PubMed/Corpus">000946</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000946</idno>
<idno type="wicri:Area/PubMed/Curation">000943</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000943</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000943</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000943</idno>
<idno type="wicri:Area/Ncbi/Merge">004B72</idno>
<idno type="wicri:Area/Ncbi/Curation">004B72</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004B72</idno>
<idno type="wicri:Area/Main/Merge">000B28</idno>
<idno type="wicri:Area/Main/Curation">000B33</idno>
<idno type="wicri:Area/Main/Exploration">000B33</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Glycaemic control and hypoglycaemia in people with type 2 diabetes switching from twice-daily basal insulin to once-daily insulin glargine 300 U/mL or insulin glargine 100 U/mL (EDITION 1 and EDITION 2 subgroup analysis).</title>
<author><name sortKey="Roussel, Ronan" sort="Roussel, Ronan" uniqKey="Roussel R" first="Ronan" last="Roussel">Ronan Roussel</name>
<affiliation wicri:level="3"><nlm:affiliation>INSERM, UMRS 1138, Centre de Recherche des Cordeliers, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>INSERM, UMRS 1138, Centre de Recherche des Cordeliers, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="D Emden, Michael C" sort="D Emden, Michael C" uniqKey="D Emden M" first="Michael C" last="D'Emden">Michael C. D'Emden</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Endocrinology and Diabetes, Royal Brisbane and Women's Hospital, Brisbane, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Endocrinology and Diabetes, Royal Brisbane and Women's Hospital, Brisbane</wicri:regionArea>
<wicri:noRegion>Brisbane</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Fisher, Miles" sort="Fisher, Miles" uniqKey="Fisher M" first="Miles" last="Fisher">Miles Fisher</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Diabetes, Endocrinology and Clinical Pharmacology, Glasgow Royal Infirmary, Glasgow, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Diabetes, Endocrinology and Clinical Pharmacology, Glasgow Royal Infirmary, Glasgow</wicri:regionArea>
<wicri:noRegion>Glasgow</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ampudia Blasco, F Javier" sort="Ampudia Blasco, F Javier" uniqKey="Ampudia Blasco F" first="F Javier" last="Ampudia-Blasco">F Javier Ampudia-Blasco</name>
<affiliation wicri:level="1"><nlm:affiliation>Diabetes Reference Unit, Clinic University Hospital, Valencia, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Diabetes Reference Unit, Clinic University Hospital, Valencia</wicri:regionArea>
<wicri:noRegion>Valencia</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Stella, Peter" sort="Stella, Peter" uniqKey="Stella P" first="Peter" last="Stella">Peter Stella</name>
<affiliation wicri:level="3"><nlm:affiliation>Sanofi, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Sanofi, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Bizet, Florence" sort="Bizet, Florence" uniqKey="Bizet F" first="Florence" last="Bizet">Florence Bizet</name>
<affiliation wicri:level="3"><nlm:affiliation>Sanofi, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Sanofi, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Cali, Anna M G" sort="Cali, Anna M G" uniqKey="Cali A" first="Anna M G" last="Cali">Anna M G. Cali</name>
<affiliation wicri:level="3"><nlm:affiliation>Sanofi, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Sanofi, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Wysham, Carol H" sort="Wysham, Carol H" uniqKey="Wysham C" first="Carol H" last="Wysham">Carol H. Wysham</name>
<affiliation wicri:level="2"><nlm:affiliation>Diabetes and Endocrinology Center, Rockwood Clinic, Spokane, Washington.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Washington (État)</region>
</placeName>
<wicri:cityArea>Diabetes and Endocrinology Center, Rockwood Clinic, Spokane</wicri:cityArea>
</affiliation>
</author>
</analytic>
<series><title level="j">Diabetes, obesity & metabolism</title>
<idno type="eISSN">1463-1326</idno>
<imprint><date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">In this post hoc analysis we compared glycaemic control and hypoglycaemia between insulin glargine 300 U/mL (Gla-300) and glargine 100 U/mL (Gla-100) administered once daily in people with type 2 diabetes (T2DM) from the EDITION 1 (basal plus mealtime insulin) and EDITION 2 (basal insulin plus oral antihyperglycaemic drugs) trials who were previously receiving twice-daily insulin. At randomization, 16.9% and 20.0% of people in EDITION 1 and 2, respectively, were receiving twice-daily basal insulin. Glycated haemoglobin change from baseline to Month 6 was similar over 6 months with Gla-300 or Gla-100 (least squares mean difference -0.01%; 95% confidence interval [CI] -0.27 to 0.24] in EDITION 1 and 0.16%; 95% CI -0.25 to 0.57, in EDITION 2). Participants previously receiving twice-daily insulin in EDITION 1 had a lower risk of confirmed (≤3.9 mmol/L [≤70 mg/dL]) or severe hypoglycaemia with Gla-300 vs Gla-100 at night (00:00-05:59 hours), but not at any time (24 hours); in EDITION 2 the risk was reduced at night and any time (24 hours). In conclusion, Gla-300 provided similar glycaemic control with less hypoglycaemia compared with Gla-100 in people with T2DM switching from twice-daily to once-daily basal insulin.</div>
</front>
</TEI>
<affiliations><list><country><li>Australie</li>
<li>Espagne</li>
<li>France</li>
<li>Royaume-Uni</li>
<li>États-Unis</li>
</country>
<region><li>Washington (État)</li>
<li>Île-de-France</li>
</region>
<settlement><li>Paris</li>
</settlement>
</list>
<tree><country name="France"><region name="Île-de-France"><name sortKey="Roussel, Ronan" sort="Roussel, Ronan" uniqKey="Roussel R" first="Ronan" last="Roussel">Ronan Roussel</name>
</region>
<name sortKey="Bizet, Florence" sort="Bizet, Florence" uniqKey="Bizet F" first="Florence" last="Bizet">Florence Bizet</name>
<name sortKey="Cali, Anna M G" sort="Cali, Anna M G" uniqKey="Cali A" first="Anna M G" last="Cali">Anna M G. Cali</name>
<name sortKey="Stella, Peter" sort="Stella, Peter" uniqKey="Stella P" first="Peter" last="Stella">Peter Stella</name>
</country>
<country name="Australie"><noRegion><name sortKey="D Emden, Michael C" sort="D Emden, Michael C" uniqKey="D Emden M" first="Michael C" last="D'Emden">Michael C. D'Emden</name>
</noRegion>
</country>
<country name="Royaume-Uni"><noRegion><name sortKey="Fisher, Miles" sort="Fisher, Miles" uniqKey="Fisher M" first="Miles" last="Fisher">Miles Fisher</name>
</noRegion>
</country>
<country name="Espagne"><noRegion><name sortKey="Ampudia Blasco, F Javier" sort="Ampudia Blasco, F Javier" uniqKey="Ampudia Blasco F" first="F Javier" last="Ampudia-Blasco">F Javier Ampudia-Blasco</name>
</noRegion>
</country>
<country name="États-Unis"><region name="Washington (État)"><name sortKey="Wysham, Carol H" sort="Wysham, Carol H" uniqKey="Wysham C" first="Carol H" last="Wysham">Carol H. Wysham</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B33 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000B33 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:28736942
   |texte=   Glycaemic control and hypoglycaemia in people with type 2 diabetes switching from twice-daily basal insulin to once-daily insulin glargine 300 U/mL or insulin glargine 100 U/mL (EDITION 1 and EDITION 2 subgroup analysis).
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:28736942" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

Serveur d'exploration sur les relations entre la France et l'Australie

Glycaemic control and hypoglycaemia in people with type 2 diabetes switching from twice-daily basal insulin to once-daily insulin glargine 300 U/mL or insulin glargine 100 U/mL (EDITION 1 and EDITION 2 subgroup analysis).

Glycaemic control and hypoglycaemia in people with type 2 diabetes switching from twice-daily basal insulin to once-daily insulin glargine 300 U/mL or insulin glargine 100 U/mL (EDITION 1 and EDITION 2 subgroup analysis).

Source :

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.